sharecast

{{ storiesRelated.title }}

Small Caps News
27 Aug
dl faron pharma aim pharmaceuticals drugs medicine medical research and development logo
Faron Pharmaceuticals candidate gets FDA fast track designation

Clinical-stage biopharmaceutical company Faron Pharmaceuticals announced on Tuesday that its lead candidate, bexmarilimab, has been granted fast track designation by the US Food and Drug Administration (FDA), for the treatment of relapsed or refractory myelodysplastic syndrome (r/r MDS) in combination with azacitidine.

27 Aug
dl prospex energy plc aim energy oil gas and coal oil crude producers logo 20230214
Prospex acquires 7.5pc stake in Viura gas field

Prospex Energy, an investment company focused on European gas and power projects, announced the successfully completed acquisition of a 7. 5% stake in Heyco Energy Iberia (HEI) on Tuesday, the majority owner of the Viura gas field in northern Spain.

27 Aug
dl goldplat aim mining miner producer gold precious metals south africa ghana logo
Goldplat profitability improves in fourth quarter

South Africa and Ghana-focussed gold recovery specialist Goldplat announced a substantial increase in fourth-quarter profitability on Tuesday.

27 Aug
dl diaceutics aim diagnostics commercialisation pharmaceutical services medicine drugs testing logo
Diaceutics reports progress with rare-disease offerings

Diaceutics announced a significant enhancement to its rare-disease offerings on Tuesday, leading to the acquisition of a new contract aimed at supporting the commercialisation of a rare-disease therapy.

27 Aug
dl belluscura plc aim health care healthcare medical equipment and services medical equipment logo 20230113
Belluscura shares surge on strong sales momentum, improved outlook

Belluscura, a developer of lightweight and portable oxygen enrichment technology, reported strong sales momentum and an optimistic trading outlook on Tuesday, as it prepared for the full commercial launch of its new ‘DISCOV-R’ portable oxygen concentrator.

27 Aug
dl rua life sciences aim investing research technology health medica devices logo
RUA Life Sciences reports strong start to financial year

RUA Life Sciences, a medical device company specialising in implantable textiles and biostable polymers, reported a strong start to its financial year on Tuesday, with trading in the first four months exceeding management expectations.

27 Aug
dl shield therapeutics aim pharmaceutical medicine research development drug logo
Shield Therapeutics iron deficiency treatment approved in Canada

Commercial-stage pharmaceutical company Shield Therapeutics announced on Tuesday that ‘ACCRUFeR’, or ferric maltol, had been approved by Health Canada as a prescription drug for the treatment of adults with iron deficiency anaemia (IDA).